This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Newsletter Archive
Men's Health Weekly
Uroalerts Men's Health Weekly
April 21, 2026
Videos
Peer-to-Peer Clinical Conversations
The PEACE-6-PR Trial "Presentation" - Désirée Deandreis
Désirée Deandreis
At the 2026 UCSF-UCLA PSMA Conference, Désirée Deandreis describes the PEACE-6 program's four phase three trials in metastatic hormone-sensitive prostate cancer.
View
Management of Post-Micturition Dribble in Men - Ahmed Albakr
Ahmed Albakr
Ahmed Albakr discusses a systematic review of post-micturition dribble management.
View
Beyond the Abstracts
Lymphovascular Invasion Predicts Cancer-Specific Mortality in Penile Localized Squamous Cell Carcinoma - Beyond the Abstract
A Nationwide Analysis of Post-Penile Prosthesis Infection: Do Hospital and Surgeon Volume Matter? - Beyond the Abstract
Articles
Editor Selected Abstracts and Commentaries
Androgen Deficiency
Congenital aromatase deficiency in an adult male: A case report of clinical course and symptom reversal with estrogen supplementation.
Male Infertility
Integrating Sperm Microscopy, Environmental Exposures, and Lifestyle Factors for Male Fertility Analysis: Protocol for the Nippon Semen and Environmental Exposure Database (N-SEED) Cross-Sectional Study.
Boosting Male Fertility: The Impact of Gonadotropin Therapy on Hypogonadotropic Hypogonadism-A Systematic Review and Meta-Analysis.
Paternal reproductive health in focus: new World Health Organization infertility guideline interpreted through a biological and clinical lens.
From ChatGPT to UroGPT: A guideline-trained artificial intelligence model for male infertility.
Peyronie's Disease
Evaluation of collagen membrane grafting in managing Peyronie's disease and penile curvature: a pilot study.
Prostatitis
No causal effect between prostatitis and erectile dysfunction: Insights from a 2-sample bidirectional Mendelian randomization study.
Erectile Dysfunction
Prevalence and clinical characteristics of erectile dysfunction among men with type 2 diabetes in primary care: A cross-sectional study in Catalonia.
Are Reference Intervals for Calculated Free Testosterone in Healthy Men Reliable Also in Men With Erectile Dysfunction? Findings From a Cross-Sectional Study.
Prevalence of erectile dysfunction among healthy and sexually active Malaysian men aged 18 to 39 years.
Analysis of patients with erectile dysfunction undergoing coronary angiography in Austria-a cross-sectional study.
Association Between Parameters of Penile Doppler Ultrasound and Cardiovascular Risk in Patients with Erectile Dysfunction: A Single-Center Retrospective Study.
BPH - Benign Prostatic Enlargement
The SUMMIT Study: A real-world, clinical study to evaluate the performance of the Optilume® BPH Catheter System in men with symptomatic Benign Prostatic Hyperplasia (BPH).
Combined anatomical parameters predict benign prostatic hyperplasia-related lower urinary tract symptom severity: a volume-stratified study.
Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential.
Penile & Urethral Cancers
Organ-sparing radiotherapy in penile cancer: therapeutic approaches.
Fungating Mass of the Glans Penis: A Case Report and Discussion on Penile Squamous Cell Carcinoma.
Predicting inguinal lymph node metastasis in penile squamous cell carcinoma, from imaging, molecular biomarkers to multimodal AI: a narrative review.
Testicular Cancer
Metabolic profile and skeletal muscle as predictors of survival in testicular germ cell tumors.
Persistent suicide risk in survivors of testicular cancer: A population-based cohort study.
Genome-Wide Copy-Number Landscape of Germ Cell Tumors With Synchronous Conventional and "Somatic-Type" Malignancy Components.
Intranuclear Peripheral Overexpression of Pituitary-Tumor-Transforming Gene 1: Immunohistochemical Biomarker of Lymph Node Involvement in Testicular Seminoma.
Prostate Cancer
Prostate cancer mortality among men with and without comorbidity: Long-term results from the European randomized study of screening for prostate cancer Rotterdam.
Predicting High-Dose-Rate Brachytherapy Boost Benefit Using Hypoxia and Angiogenesis Gene Expression in Localised Prostate Cancer.
Lessons from the margins: Narratives of black men living beyond prostate cancer.
Clinical validation of a Novel Robotic Device for MR-Guided Prostate Biopsy: Initial Patient Experience.
Protein Kinase D1 Translocates PARP1 to the Membrane and Is Associated With Increased Sensitivity to Cell Viability Inhibition by PARP1 Inhibitor Olaparib.
Redefining standards: a comprehensive systematic review of practice changing advances in GU oncology from ASCO and ESMO 2025.
Health-related Quality of Life With ARPIs in mHSPC: Insights From a Network Meta-analysis.
Phosphorescent Iridium Hydrazinonicotinic Acid (HYNIC) Complexes That Bind to Prostate Specific Membrane Antigen: Potential Photodynamic Therapy of Prostate Cancer.
Racial disparity in microvascular function among non-Hispanic white and non-Hispanic black men with newly diagnosed prostate cancer.
Predicting clinically significant prostate cancer with or without digital rectal exam and MRI data using ClarityDX Prostate models.
Risk-Adapted Follow-up After Negative MRI-Targeted Biopsy in PI-RADS 3-5 Lesions: A Clinical Cohort Study With Diagnostic Stewardship Modeling.
LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer.
Lymphedema and self-reported swelling among Danish survivors of prostate cancer - prevalence, clinical associations and functional implications.
Predictive value of early PSMA upregulation for the response to enzalutamide ± 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial.
Radiotherapy in Men with De Novo Metastatic Prostate Cancer.
Re-Evaluating the Role of Locoregional Therapy in Metastatic Prostate Cancer: A Review of Current Evidence and Evolving Clinical Approaches.
Comparative Performance of Prostate Cancer Risk Prediction Tools in Gay, Bisexual, and Other Men Who Have Sex with Men Versus Heterosexual Men.
Real-World Effectiveness and Treatment Persistence of Darolutamide, Apalutamide, and Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Study.
Stockholm3 versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial - Beyond the Abstract
The Role of Multimodality Imaging in Selection, Response Assessment, and Follow-up of Patients Receiving 177Lutetium-PSMA-Therapy - Beyond the Abstract
Natural History of Untreated Prostate Cancer: A Comprehensive Review of Long-Term Progression Patterns and Survival Outcomes - Beyond the Abstract
Survival of Individuals Diagnosed With High-Risk, Regional, and Metastatic Prostate Cancer by Culturally and Linguistically Diverse Status: A Retrospective Cohort Study Set in Victoria, Australia.
Performance of an Artificial Intelligence Foundation Model for Prostate Radiotherapy Segmentation.
Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancer.
Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET-CT in Characterising Bone Lesions in Prostate Cancer: A Single-Centre Study.
Harnessing Artificial Intelligence for Risk Stratification and Outcome Prediction in Urologic Cancers: A Systematic Review.
Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01.
A Cost-Analysis and Micro-Costing Study of the Man Van Project: Comparing Prostate-Specific Antigen Testing Via a Nurse-Led Mobile Service with Primary Care - Beyond the Abstract
A Prolonged Nightly Fasting Plus Telehealth Coaching Intervention (PNF+) for Men on Androgen Deprivation Therapy for PCa: A Pilot Feasibility Randomized Controlled Trial.
ANGPTL3, Apo CIII, Leptin and Triglycerides Are Elevated in Metastatic Prostate Cancer.
Pathological Stage and Grade Determine the Impact of Focal Versus Extensive Positive Surgical Margins After Radical Prostatectomy.
Genomic Analysis of Puerto Rican Hispanic/Latino Men with Prostate Cancer.
Urine-Based Machine Learning Assay Detects Prostate Cancer.
CONNECT WITH US
Questions or Comments? Email us at
editors@urotoday.com
Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523
You are receiving this email because you have chosen to receive emails from UroToday.
Add us to your address book
View this email as a web page
Forward to a colleague
Manage your subscriptions
Unsubscribe
Copyright ©2026 Digital Science Press, LLC
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free